Viewing Study NCT03895528


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-01-13 @ 9:52 AM
Study NCT ID: NCT03895528
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2021-04-15
First Post: 2019-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy
Sponsor: Eiger BioPharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module References Module